Europe Pharmaceutical Intermediates Market
Europe consists of five major countries namely Germany, the UK, France, Spain, and Italy. The market is also evaluated for the Rest of Europe market. The region holds second-largest position for the pharmaceutical intermediate market at a global level. The growth of the market is driven by increasing pharmaceutical production, growing innovations by biopharmaceutical companies, rising government support and development for the production facilities and infrastructures. The pharmaceutical intermediates market in the UK is primarily driven by government support. The government investments have broadly driven the productivity and activities and have allowed for the future fund, sustainable innovation funds to build the country’s pharmaceutical industry. The government has been continuously increasing in research and developments. The pharmaceutical industry in the UK is expected to be growing significantly in the coming future. The industry has shown its strength and sustainability during the global economic crises in 2020, caused due to COVID-19 pandemic. Increase in R&D investments by pharmaceutical companies is the major factor driving the growth of the Europe pharmaceutical intermediates market.
Among all European countries, Spain, Italy, Germany, France, and the UK are most affected due to the increasing number of coronavirus cases and deaths associated with it. As per the Worldometer as of April, 2021, in Spain, Italy, Germany, France, and UK, the number of cases is 3,370,256; 3,779,594; 3,021,064; 5,067,216; and 4,373,343 respectively and number of deaths are also high. Various companies have undergone severe losses in the last quarter of 2019 and have negatively impacted the year 2020. As to control the spread of disease, countries have imposed complete lockdown. The lockdown has resulted in slower economies due to closed trades and business. The health and wellness market in Europe is observing steady growth due to the outbreak of coronavirus pandemic. Europeans are looking for different and natural ways of staying healthy and enhance their immune system. Lockdown and quarantine measures in Europe has led to a change in consumer buying habits. Some health categories are witnessing short-term decline in growth, while few are having positive effect on the sales of vitamins, dietary supplements, and analgesics with a strong focus on immunity and prevention. So, health supplements that were trending fine before the lockdown scenario have suddenly gained more attention as more consumers are looking for products that can help them in staying healthy. Multivitamins is one of the products that is gaining excellent popularity during pandemic. So, there is increased interest in how vitamins and health supplements can help people with their health and wellness in the coronavirus era. In France, specialist organic food shops have reported sales increases of over 40 percent. Holland & Barrett, the leading health food retailer in the UK, put a cap on supplement purchases due to its rising demand. Online retailer Healthspan reported that at end of March 2020, the sales of vitamin C supplements had tripled in a week. These factors are likely to have positive impact on the market growth.
Strategic insights for the Europe Pharmaceutical Intermediates provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 7,890.84 Million |
| Market Size by 2028 | US$ 10,135.51 Million |
| Global CAGR (2021 - 2028) | 3.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
The geographic scope of the Europe Pharmaceutical Intermediates refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The pharmaceutical intermediates market in Europe is expected to grow from US$ 7,890.84 million in 2021 to US$ 10,135.51 million by 2028; it is estimated to grow at a CAGR of 3.6% from 2021 to 2028. Artificial intelligence (AI) is emerging as important tool as it helps understand the action mechanism of drugs. The use of AI tools has already been proven to accelerate the process of discovering new candidate therapeutics; the process that earlier used to take years for completion can now be accomplished within months using the AI. in addition to reducing the timelines of drug discovery, AI also helps enhance the agility of the research process, increase the accuracy of predictions on the efficacy and drug safety, and boost the speed and precision of discovery as well as preclinical testing, thereby enabling more competitive R&D strategies. Many of pharmaceutical players are collaborating with AI companies for drug discovery. For instance, In June 2017, Genentech collaborated with GNS Healthcare to use the proprietary REFS casual machine learning and simulation AI platform of the later to identify and validate novel cancer drug targets. Similarly, GlaxoSmithKline (GSK) collaborated with Insilico Medicine, a Baltimore-based AI-driven company, to explore the AI capability of Insilico for easing the process of identification of novel biological targets.
The Europe pharmaceutical intermediates market is segmented on the bases of type, application, distribution channel, and country. Based on type, the market is segmented into GMP and Non GMP. The GMP segment dominated the market in 2020 is expected to be the fastest growing during the forecast period. On the basis of application, the pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. The others segment dominated the market in 2020 and vitamins segment is expected to be the fastest growing during the forecast period. On the basis of distribution channel, the pharmaceutical intermediates market is segmented into distributor and direct sales. The direct sales segment dominated the market in 2020 and distributor segment is expected to be the fastest growing during the forecast period.
A few major primary and secondary sources referred to for preparing this report on the pharmaceutical intermediates market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BASF SE; chiracon GmbH; Codexis; Dextra Laboratories Limited; Dishman Carbogen Amcis Ltd; Midas Pharma GmbH; Pfizer Inc.; and Sanofi are among others.
The Europe Pharmaceutical Intermediates Market is valued at US$ 7,890.84 Million in 2021, it is projected to reach US$ 10,135.51 Million by 2028.
As per our report Europe Pharmaceutical Intermediates Market, the market size is valued at US$ 7,890.84 Million in 2021, projecting it to reach US$ 10,135.51 Million by 2028. This translates to a CAGR of approximately 3.6% during the forecast period.
The Europe Pharmaceutical Intermediates Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Pharmaceutical Intermediates Market report:
The Europe Pharmaceutical Intermediates Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Pharmaceutical Intermediates Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Pharmaceutical Intermediates Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Pharmaceutical Intermediates Market
